Marvin Samuel Tolentino Pineda/iStock via Getty Images
- Roche (OTCQX:RHHBY) announced that the U.S. FDA has approved Susvimo 100 mg/mL for the treatment of diabetic retinopathy.
- The approval allows U.S. retina specialists to offer Susvimo to DR patients who have previously responded to at least two anti-VEGF injections.
